The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating

Biomaterials

Volumn 32, Issue 30, 2011, Pages 7543-7554

  Crouzier, Thomas ^a   Sailhan, Frédéric ^b,c   Becquart, Pierre ^b   Guillot, Raphael ^a   Logeart Avramoglou, Delphine ^b   Picart, Catherine ^a  

^a LABORATOIRE DES MATÉRIAUX ET DU GÉNIE PHYSIQUE   (France)

^b Paris university   (France)

^c Hôpital Cochin ^*  (France)

Author keywords

Bone morphogenetic protein 2 (BMP 2); Bone tissue engineering; Controlled drug release; Osteoinduction; Polyelectrolyte multiplayer; Polysaccharides

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE; BONE TISSUE ENGINEERING; C2C12 CELLS; CELL MARKERS; COMPLEX GEOMETRIES; CONTROLLED DRUG RELEASE; IMPLANTABLE MATERIALS; IN-VITRO; IN-VIVO; LUCIFERASE EXPRESSION; MACROPOROUS; METAL ALLOYS; MORPHOGENIC; OSTEOCONDUCTIVE; OSTEOINDUCTION; OSTEOINDUCTIVE PROPERTIES; POLYELECTROLYTE MULTILAYER FILM; POROUS CERAMICS; RHBMP-2;

BIOMATERIALS; BONE; COATINGS; GRANULATION; MULTILAYERS; PHOSPHATASES; POLYELECTROLYTES; PROTEINS; TISSUE; TISSUE ENGINEERING;

MULTILAYER FILMS;

ALKALINE PHOSPHATASE; BIOCERAMICS; BONE MORPHOGENETIC PROTEIN 2; CELL MARKER; LUCIFERASE; POLYELECTROLYTE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE CONDUCTION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; DRUG ACTIVITY; DRUG ADSORPTION; DRUG GRANULE; ENZYME ACTIVITY; FILM COATING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATES; CELL LINE; CERAMICS; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DURAPATITE; HUMANS; MICE; MYOBLASTS, SKELETAL; OSTEOGENESIS; POROSITY; RECOMBINANT PROTEINS; TISSUE ENGINEERING;

EID: 80051550264     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.06.062     Document Type: Article

References (57)

1. Axelrad T.W., Kakar S., Einhorn T.A. New technologies for the enhancement of skeletal repair. Injury-Int J Care Inj 2007, 38:S49-S62.
2. Schmidmaier G., Schwabe P., Strobel C., Wildemann B. Carrier systems and application of growth factors in orthopaedics. Injury-Int J Care Inj 2008, 39(Suppl. 2):S37-S43.
3. Haidar Z.S., Hamdy R.C., Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett 2009, 31:1825-1835.
4. Heary R.F., Schlenk R.P., Sacchieri T.A., Barone D., Brotea C. Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery 2002, 50:510-516.
5. Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: an update. Injury-Int J Care Inj 2005, 36:20-27.
6. Bohner M., Gbureck U., Barralet J.E. Technological issues for the development of more efficient calcium phosphate bone cements: a critical assessment. Biomaterials 2005, 26:6423-6429.
7. Seeherman H., Wozney J., Li R. Bone morphogenetic protein delivery systems. Spine 2002, 27:S16-S23.
8. Li R.H., Wozney J.M. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 2001, 19:255-265.
9. Geiger M., Li R.H., Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003, 55:1613-1629.
10. Schuessele A., Mayr H., Tessmar J., Goepferich A. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J Biomed Mater Res A 2009, 90:959-971.
11. Schopper C., Moser D., Spassova E., Goriwoda W., Lagogiannis G., Hoering B., et al. Bone regeneration using a naturally grown HA/TCP carrier loaded with rh BMP-2 is independent of barrier-membrane effects. J Biomed Mater Res A 2008, 85:954-963.
12. Abarrategi A., Moreno-Vicente C., Ramos V., Aranaz I., Sanz Casado J.V., Lopez-Lacomba J.L. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application. Tissue Eng Part A 2008, 14:1305-1319.
13. Wu G., Liu Y., Iizuka T., Hunziker E.B. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. Biomaterials 2010, 31:7485-7493.
14. Dierich A., Le Guen E., Messaddeq N., Stoltz S., Netter P., Schaaf P., et al. Bone formation mediated by synergy-acting growth factors embedded in a polyelectrolyte multilayer film. Adv Mater 2007, 19:693-697.
15. Crouzier T., Ren K., Nicolas C., Roy C., Picart C. Layer-by-Layer films as a biomimetic reservoir for rhBMP-2 delivery: controlled differentiation of myoblasts to osteoblasts. Small 2009, 5:598-608.
16. Crouzier T., Szarpak A., Boudou T., Auzely-Velty R., Picart C. Polysaccharide-blend multilayers containing hyaluronan and heparin as a delivery system for rhBMP-2. Small 2010, 6:651-662.
17. Facca S., Cortez C., Mendoza-Palomares C., Messadeq N., Dierich A., Johnston A.P., et al. Active multilayered capsules for in vivo bone formation. Proc Natl Acad Sci U S A 2010, 107:3406-3411.
18. Macdonald M.L., Samuel R.E., Shah N.J., Padera R.F., Beben Y.M., Hammond P.T. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 2011, 32:1446-1453.
19. van den Beucken J.J., Walboomers X.F., Boerman O.C., Vos M.R., Sommerdijk N.A., Hayakawa T., et al. Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2. J Control Release 2006, 113:63-72.
20. Boudou T., Crouzier T., Ren K., Blin G., Picart C. Multiple functionalities of polyelectrolyte mulitlayer films: new biomedical applications. Adv Mater 2010, 22:441-467.
21. Kuhl P.R., Griffith-Cima L.G. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nat Med 1996, 2:1022-1027.
22. Fan V.H., Tamama K., Au A., Littrell R., Richardson L.B., Wright J.W., et al. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 2007, 25:1241-1251.
23. Tadic D., Epple M. A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone. Biomaterials 2004, 25:987-994.
24. Schneider A., Francius G., Obeid R., Schwinté P., Frisch B., Schaaf P., et al. Polyelectrolyte multilayer with tunable young's modulus: influence on cell adhesion. Langmuir 2006, 22:1193-1200.
25. Picart C., Schneider A., Etienne O., Mutterer J., Egles C., Jessel N., et al. Controlled degradability of polysaccharides multilayer films in vitro and in vivo. Adv Funct Mater 2005, 15:1771-1780.
26. Ren K., Crouzier T., Roy C., Picart C. Polyelectrolyte multilayer films of controlled stiffness modulate myoblast differentiation. Adv Funct Mater 2008, 18:1378-1389.
27. Picart C., Mutterer J., Richert L., Luo Y., Prestwich G.D., Schaaf P., et al. Molecular basis for the explanation of the exponential growth of polyelectrolyte multilayers. Proc Natl Acad Sci 2002, 99:12531-12535.
28. Salacinski P.R., McLean C., Sykes J.E., Clement-Jones V.V., Lowry P.J. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem 1981, 117:136-146.
29. Logeart-Avramoglou D., Bourguignon M., Oudina K., Ten Dijke P., Petite H. An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct. Anal Biochem 2006, 349:78-86.
30. Degat M.C., Dubreucq G., Meunier A., Dahri-Correia L., Sedel L., Petite H., et al. Enhancement of the biological activity of BMP-2 by synthetic dextran derivatives. J Biomed Mater Res A 2009, 88:174-183.
31. Guillemin G., Meunier A., Dallant P., Christel P., Pouliquen J.C., Sedel L. Comparison of coral resorption and bone apposition with two natural corals of different porosities. J Biomed Mater Res 1989, 23:765-779.
32. Autefage H., Briand-Mesange F., Cazalbou S., Drouet C., Fourmy D., Goncalves S., et al. Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramics. J Biomed Mater Res B Appl Biomater 2009, 91:706-715.
33. Roach P., Farrar D., Perry C.C. Interpretation of protein adsorption: surface-induced conformational changes. J Am Chem Soc 2005, 127:8168-8173.
34. Kanakaris N.K., Calori G.M., Verdonk R., Burssens P., De Biase P., Capanna R., et al. Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. Injury 2008, 39(Suppl. 2):S83-S90.
35. Dawson E., Bae H.W., Burkus J.K., Stambough J.L., Glassman S.D. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Jt Surg Am 2009, 91:1604-1613.
36. Sandhu H.S., Khan S.N., Suh D.Y., Boden S.D. Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: an overview. Eur Spine J 2001, 10(Suppl. 2):S122-S131.
37. Khan S.N., Lane J.M. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Expert Opin Biol Ther 2004, 4:741-748.
38. Lefort M., Boulmedais F., Jierry L., Gonthier E., Voegel J.C., Hemmerle J., et al. Simultaneous spray coating of interacting species: general rules governing the poly(styrene sulfonate)/poly(allylamine) system. Langmuir 2011, 27:4653-4660.
39. Rinckenbach S., Hemmerle J., Dieval F., Arntz Y., Kretz J.G., Durand B., et al. Characterization of polyelectrolyte multilayer films on polyethylene terephtalate vascular prostheses under mechanical stretching. J Biomed Mat Res Part A 2007, 84A:576-588.
40. Brunot C., Grosgogeat B., Picart C., Lagneau C., Jaffrezic-Renault N., Ponsonnet L. Response of fibroblast activity and polyelectrolyte multilayer films coating titanium. Dental Mat 2008.
41. Boix T., Gomez-Morales J., Torrent-Burgues J., Monfort A., Puigdomenech P., Rodriguez-Clemente R. Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite. J Inorg Biochem 2005, 99:1043-1050.
42. Dong X., Wang Q., Wu T., Pan H. Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J 2007, 93:750-759.
43. Dohzono S., Imai Y., Nakamura H., Wakitani S., Takaoka K. Successful spinal fusion by E. coli-derived BMP-2-adsorbed porous beta-TCP granules: a pilot study. Clin Orthop Relat Res 2009, 467:3206-3212.
44. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766.
45. Sieber C., Kopf J., Hiepen C., Knaus P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev 2009, 20:343-355.
46. Crouzier T., Picart C. Ion pairing and hydration in polyelectrolyte multilayer films containing polysaccharides. Biomacromolecules 2009, 10:433-442.
47. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
48. Schindeler A., Liu R., Little D.G. The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells. Differentiation 2009, 77:12-18.
49. Habibovic P., Sees T.M., van den Doel M.A., van Blitterswijk C.A., de Groot K. Osteoinduction by biomaterials-physicochemical and structural influences. J Biomed Mater Res A 2006, 77:747-762.
50. Sharpe J.R., Sammons R.L., Marquis P.M. Effect of pH on protein adsorption to hydroxyapatite and tricalcium phosphate ceramics. Biomaterials 1997, 18:471-476.
51. Uludag H., D'Augusta D., Palmer R., Timony G., Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mat Res Part A 1999, 46:193-202.
52. Aono A., Hazama M., Notoya K., Taketomi S., Yamasaki H., Tsukuda R., et al. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 1995, 210:670-677.
53. Sailhan F., Gleyzolle B., Parot R., Guerini H., Viguier E. Rh-BMP-2 in distraction osteogenesis: dose effect and premature consolidation. Injury-Int J Care Inj 2010, 41:680-686.
54. Kim H.D., Valentini R.F. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 2002, 59:573-584.
55. Hollinger J.O., Uludag H., Winn S.R. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 1998, 31:303-318.
56. Burkus J.K., Sandhu H.S., Gornet M.F. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft. Spine 2006, 31:775-781.
57. McClellan J.W., Mulconrey D.S., Forbes R.J., Fullmer N. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006, 19:483-486.